Literature DB >> 22942216

Autonomic dysfunction in parkinsonian disorders: assessment and pathophysiology.

Masato Asahina1, Ekawat Vichayanrat, David A Low, Valeria Iodice, Christopher J Mathias.   

Abstract

Parkinson's disease (PD) is a progressive neurodegenerative disorder characterised by motor dysfunction (parkinsonism) and several non-motor features. Dysautonomia is a significant non-motor feature as well as a neuropsychiatric symptom. Autonomic dysfunction can occur even in the early stages of PD, often preceding the onset of the classic motor symptoms of PD. The patterns of autonomic features in PD are different from other parkinsonian disorders. Detection of autonomic dysfunction may therefore be helpful in diagnosing PD in the early or pre-motor stages, and/or in differentiating it from other parkinsonian disorders, such as multiple system atrophy and progressive supuranuclear palsy. The aim of this review is to describe aspects of autonomic dysfunction, including symptoms, assessment and pathophysiology, resulting from autonomic impairment in PD and other parkinsonian syndromes.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22942216     DOI: 10.1136/jnnp-2012-303135

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  36 in total

1.  The use of botulinum toxin in the treatment of sialorrhea in parkinsonian disorders.

Authors:  María T Gómez-Caravaca; María T Cáceres-Redondo; Ismael Huertas-Fernández; Laura Vargas-González; Fátima Carrillo; Manuel Carballo; Pablo Mir
Journal:  Neurol Sci       Date:  2014-09-20       Impact factor: 3.307

2.  Neurotoxin-Induced Catecholaminergic Loss in the Colonic Myenteric Plexus of Rhesus Monkeys.

Authors:  Jeanette M Shultz; Henry Resnikoff; Viktorya Bondarenko; Valerie Joers; Andres Mejia; Heather Simmons; Marina E Emborg
Journal:  J Alzheimers Dis Parkinsonism       Date:  2016-11-03

3.  Association of Autonomic Dysfunction With Disease Progression and Survival in Parkinson Disease.

Authors:  Eduardo De Pablo-Fernandez; Carmen Tur; Tamas Revesz; Andrew J Lees; Janice L Holton; Thomas T Warner
Journal:  JAMA Neurol       Date:  2017-08-01       Impact factor: 18.302

4.  Non-dipping nocturnal blood pressure and psychosis parameters in Parkinson disease.

Authors:  E Stuebner; E Vichayanrat; D A Low; C J Mathias; S Isenmann; C A Haensch
Journal:  Clin Auton Res       Date:  2015-02-18       Impact factor: 4.435

Review 5.  Mesenchymal Stromal Cell Therapies for Neurodegenerative Diseases.

Authors:  Nathan P Staff; David T Jones; Wolfgang Singer
Journal:  Mayo Clin Proc       Date:  2019-05       Impact factor: 7.616

6.  Influence of Deep Breathing on Heart Rate Variability in Parkinson's Disease: Co-relation with Severity of Disease and Non-Motor Symptom Scale Score.

Authors:  Mukta Pritam Bidikar; Gayatri J Jagtap; Rahul T Chakor
Journal:  J Clin Diagn Res       Date:  2014-07-20

7.  Association of depressive symptoms with circadian blood pressure alterations in Parkinson's disease.

Authors:  Davide L Vetrano; Maria S Pisciotta; Maria R Lo Monaco; Graziano Onder; Alice Laudisio; Vincenzo Brandi; Domenico La Carpia; Mauro Guglielmo; Antonio Nacchia; Domenico Fusco; Diego Ricciardi; Anna R Bentivoglio; Roberto Bernabei; Giuseppe Zuccalà
Journal:  J Neurol       Date:  2015-09-04       Impact factor: 4.849

Review 8.  Therapy-resistant symptoms in Parkinson's disease.

Authors:  Ruxandra Julia Vorovenci; Roberta Biundo; Angelo Antonini
Journal:  J Neural Transm (Vienna)       Date:  2015-09-26       Impact factor: 3.575

9.  Evaluation of Cardiac Autonomic Functions in Older Parkinson's Disease Patients: a Cross-Sectional Study.

Authors:  Ahmet Yalcin; Volkan Atmis; Ozlem Karaarslan Cengiz; Esat Cinar; Sevgi Aras; Murat Varli; Teslime Atli
Journal:  Aging Dis       Date:  2016-01-02       Impact factor: 6.745

10.  Effects of Exercise on Non-motor Symptoms in Parkinson's Disease.

Authors:  Amy W Amara; Adeel A Memon
Journal:  Clin Ther       Date:  2017-12-01       Impact factor: 3.393

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.